Safety, Immunogenicity and Reactogenicity Trial of Mencevax ACW135 Vaccine

NCT00994695 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
412
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Armauer Hansen Research Institute, Ethiopia

Collaborators